[1] O’Malley, S.S., et al. (2007). “Efficacy of Buprenorphine for Treating Alcohol Dependence.” Journal of Clinical Psychopharmacology, 27(5), 509-515.
[2] Kranzler, H.R., et al. (2011). “Buprenorphine Treatment for Alcohol Dependence: A Review.” The American Journal of Psychiatry, 168(11), 1232-1238.
[3] Strain, E.C., et al. (1999). “The Safety and Efficacy of Buprenorphine in the Treatment of Opioid Dependence.” Journal of Clinical Pharmacology, 39(8), 818-826.
[4] Seal, K.H., et al. (2012). “Substance Use Disorders in Iraq and Afghanistan Veterans in VA Healthcare, 2001–2010: Implications for Screening, Diagnosis and Treatment.” Drug and Alcohol Dependence, 124(1-2), 93-101.
[5] Petrakis, I.L., et al. (2016). “Buprenorphine and Naltrexone in the Treatment of Alcohol Use Disorders.” CNS Drugs, 30(6), 501-511.
[6] Trafton, J.A., et al. (2013). “Outcomes Associated with Buprenorphine Treatment in Veterans with Posttraumatic Stress Disorder.” Journal of Substance Abuse Treatment, 45(3), 246-255.
[7] Greene, T.C., et al. (2018). “The Impact of Buprenorphine on Treatment of Opioid Dependence in a Specialized TBI Unit: A Retrospective Cohort Study.” Brain Injury, 32(10), 1208-1213.
[8] Weiss, R.D., et al. (2011). “Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence.” Archives of General Psychiatry, 68(12), 1238-1246.
[9] Watkins, K.E., et al. (2011). “A National Study of Veterans Treatment Court Participants: Who Benefits and Who Recidivates.” Administration and Policy in Mental Health and Mental Health Services Research, 38(2), 117-127.